Talk Therapy and Psychiatry Stocks
Clinical mental health providers and neuro-pharmaceutical developers integrate traditional behavioral health services with novel therapeutic pipelines to address the growing global burden of psychiatric disorders.
As of Oct 23, 2026, Talk Therapy and Psychiatry has 4 US-listed companies worth $13.1B combined. The median member moved +8.8% over the past week; DFTX led at +11.1% and CMPS trailed at +4.0%.
Companies in Talk Therapy and Psychiatry
- LFST – Lifestance Health Group Inc, $4.6B
- DFTX – Definium Therapeutics, Inc., $4.4B
- SUPN – Supernus Pharmaceuticals Inc, $2.4B
- CMPS – Compass Pathways Plc, $1.6B